RefleXion Medical is on a mission to create a new cancer treatment modality through biological guidance. By leveraging positron emission tomography (PET) in a novel way, RefleXion’s patented technology causes tumors to continuously signal their location during treatment, potentially revolutionizing cancer care.
Potential Meets Values & Execution
A relevant mission is the cornerstone of any game-changing company, but having the values to execute is the key to long-term success. At RefleXion, our core values are present in everything we do.
Significant Innovation in Localized Cancer Treatment
With a valiant mission and fearless dedication to execute, RefleXion has inspired the confidence of many investors, all committed to advancing a new modality in cancer care. RefleXion raised more than $52M in its last round of funding from premier investment firms including Sofinnova Partners, KCK Group, Pfizer Venture Investments, Venrock and Johnson & Johnson Innovation – JJDC, Inc. The National Cancer Institute (NCI) also provided grant funding through its Small Business Innovation Research (SBIR) Program.